Treatable traits in the European U-BIOPRED adult asthma cohorts

Author:

Simpson Andrew J.12ORCID,Hekking Pieter-Paul3,Shaw Dominick E.4ORCID,Fleming Louise J.56,Roberts Graham7,Riley John H.8,Bates Stewart8,Sousa Ana R.8,Bansal Aruna T.9,Pandis Ioannis10,Sun Kai10,Bakke Per S.11,Caruso Massimo12,Dahlén Barbro13,Dahlén Sven-Erik13,Horvath Ildiko14,Krug Norbert15,Montuschi Paolo16,Sandstrom Thomas17,Singer Florian18,Adcock Ian M.56,Wagers Scott S.19,Djukanovic Ratko7,Chung Kian Fan56ORCID,Sterk Peter J.3,Fowler Stephen J.1ORCID,

Affiliation:

1. University of Manchester, and Manchester University NHS Foundation Trust; Manchester Academic Health Science Centre; Manchester UK

2. Department of Sport, Health and Exercise Science; School of Life Sciences; The University of Hull; Hull UK

3. Respiratory Medicine; Academic Medical Centre; Amsterdam The Netherlands

4. Respiratory Research Unit; University of Nottingham; Nottingham UK

5. National Heart and Lung Institute; Imperial College; London UK

6. Royal Brompton and Harefield NHS Trust; London UK

7. NIHR Southampton Respiratory Biomedical Research Unit; Clinical and Experimental Sciences and Human Development and Health; Southampton UK

8. Respiratory Therapeutic Unit; GSK; London UK

9. Acclarogen Ltd; St John's Innovation Centre; Cambridge UK

10. Data Science Institute; Imperial College; London UK

11. Department of Clinical Science; University of Bergen; Bergen Norway

12. Department of Clinical and Experimental Medicine; University of Catania; Catania Italy

13. Centre for Allergy Research; Karolinska Institutet; Stockholm Sweden

14. Department of Pulmonology; Semmelweis University; Budapest Hungary

15. Fraunhofer Institute for Toxicology and Experimental Medicine; Hannover Germany

16. Università Cattolica del Sacro Cuore; Milan Italy

17. Department of Public Health and Clinical Medicine; Umeå University; Umeå Sweden

18. Inselspital; Bern University Hospital; University of Bern; Bern Switzerland

19. BioSci Consulting; Maasmechelen Belgium

Funder

Innovative Medicines Initiative

Seventh Framework Programme

European Federation of Pharmaceutical Industries and Associations

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3